4-Methylmorpholine → N-[4-(1-t-butoxyformamido)butyryl]-beta-alanine benzyl ester

HRID 327510

Reaktionsgleichung

Reaktionsgleichung von HRID 327510
[C:1]([O:5][C:6]([NH:8][CH2:9][CH2:10][CH2:11][C:12]([OH:14])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].ClC1C(OC)=NN=NC=1OC.CN1CCOCC1.C1(C)C=CC(S(O)(=O)=O)=CC=1.[CH2:44]([O:51][C:52](=[O:56])[CH2:53][CH2:54][NH2:55])[C:45]1[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=1>C1COCC1>[CH2:44]([O:51][C:52](=[O:56])[CH2:53][CH2:54][NH:55][C:12](=[O:14])[CH2:11][CH2:10][CH2:9][NH:8][C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:7])[C:45]1[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=1

Komponenten

6

Versuchsvorschrift

4-(t-Butoxycarbonylamino)butyric acid in THF was activated with chlorodimethoxytriazine and N-methylmorpholine and reacted with β-alanine benzyl ester p-toluenesulphonate in the presence of N-methylmorpholine to give N-[4-(1-t-butoxyformamido)butyryl]-β-alanine benzyl ester, m.p. 54°-55° C.

Quellen und Nachweise

ORD-Eintrag
ord-6b91b2e342c84db5ba17df2855251161
Quelldatensatz
uspto-grants-1993_12
Patentnummer
US05273982

Verknüpfte Notizen

Wird geladen…